Trial intelligence / Profile preview

S-1 and Oxaliplatin in Gastrointestinal Cancer

NCT01608646Phase 2Unknown

Sponsor
Xijing Hospital
Start
Mar 2012
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in gastrointestinal cancer, sponsored by Xijing Hospital. Status: unknown.

02

Drugs

tegafur
03

Conditions

gastrointestinal cancer

Beyond the preview

Go deeper on NCT01608646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01608646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call